SHANNON CASE: Open Payments
NPI 1356913826 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 40 payments from 10 companies in 2025. Trend: 2023 $2,393 · 2024 $912 · 2025 $788
Food & beverage: $531Education: $257
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $223 |
| ABBVIE INC. | 14 | $156 |
| E.R. Squibb & Sons, L.L.C. | 3 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| Organon LLC | 3 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Lilly USA, LLC | 1 | $29 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Sotyktu, COSENTYX, TALTZ, ILUMYA, Winlevi.
Industry payments across NY — which companies pay providers there.
